Clinical Trial Update: Precise Infliximab Exposure and Pharmacodynamic Control [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a phase 2/3 study evaluating precise infliximab exposure and pharmacodynamic control in Crohn's disease, which is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Crohn Disease | Phase 2, Phase 3 | Status: RECRUITING